Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

盘前交易 12-18 04:49:18 EST

202.82

-9.29

-4.38%

盘前206.82

+4.00+1.97%

04:06 EST

最高213.22	最低202.09	成交量68.10万
今开210.67	昨收212.11	日振幅5.25%
总市值125.13亿	流通市值121.86亿	总股本6,170万
成交额1.40亿	换手率1.13%	流通股本6,008万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":202.82,"timestamp":1766005200000,"preClose":212.11,"halted":0,"volume":681002,"hourTrading":{"tag":"盘前","latestPrice":206.82,"preClose":202.82,"latestTime":"04:06 EST","volume":2,"amount":413.64,"timestamp":1766048792833},"delay":0,"floatShares":60083367,"shares":61695200,"eps":-4.538371,"marketStatus":"盘前交易","change":-9.29,"latestTime":"12-18 04:49:18 EST","open":210.67,"high":213.22,"low":202.09,"amount":139912317.17134,"amplitude":0.052473,"askPrice":229.6,"askSize":15,"bidPrice":197,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-4.538371,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1422421200000,"exchange":"NASDAQ","adjPreClose":202.82,"preHourTrading":{"tag":"盘前","latestPrice":206.82,"preClose":202.82,"latestTime":"04:06 EST","volume":2,"amount":413.64,"timestamp":1766048792833},"postHourTrading":{"tag":"盘后","latestPrice":202.82,"preClose":202.82,"latestTime":"17:38 EST","volume":21475,"amount":4355578.97,"timestamp":1766011081034},"volumeRatio":0.6211967772693033,"impliedVol":0.5406,"impliedVolPercentile":0.8233},"requestUrl":"/m/hq/s/ASND/wiki","defaultTab":"wiki","newsList":[{"id":"2583567786","title":"Ascendis Pharma A/S跌0.58% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583567786?lang=zh_cn&edition=full","pubTime":"2025-11-13 04:37","pubTimestamp":1762979851,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日04时37分，Ascendis Pharma A/S股票出现波动，股价急速下挫0.58%。截至发稿，该股报200.00美元/股，成交量39.7922万股，换手率0.66%，振幅2.49%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.09%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304373195009650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304373195009650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","LU0109394709.USD","LU0889565916.HKD","ASND","LU0320765992.SGD"],"gpt_icon":0},{"id":"1155392260","title":"Logista Pharma与Ascendis Pharma签署Yorvipath医院分销战略协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1155392260","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155392260?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:42","pubTimestamp":1760344975,"startTime":"0","endTime":"0","summary":"Logista Integral SA宣布，Logista Pharma与Ascendis Pharma A/S签署战略协议，就Yorvipath的医院分销达成合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","LU0310799852.SGD","LU1267930227.SGD","LU0109394709.USD","LU0496365809.HKD","LU0889565916.HKD","BK4139","LU1487256676.USD","LU0211327993.USD","LU0976567544.SGD","LU0128525689.USD","LU0211328371.USD","LU1267930490.SGD","LU1481600234.SGD","BK4585","LU0310800965.SGD","LU0889565080.SGD","LU0211326839.USD","LU0320765992.SGD","LU1481599808.USD","LU0211326755.USD","BK5010","ASND","IMB.UK"],"gpt_icon":0},{"id":"1120396018","title":"Ascendis Pharma A/S向欧洲药品管理局提交营销授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1120396018","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120396018?lang=zh_cn&edition=full","pubTime":"2025-10-09 05:35","pubTimestamp":1759959351,"startTime":"0","endTime":"0","summary":"10月8日消息 - Ascendis Pharma A/S宣布：\n该公司已向欧洲药品管理局提交TransCon® CNP的营销授权申请，用于治疗软骨发育不全症儿童。\n同时，该公司表示PDUFA目标日期已设定为2025年11月30日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0889565916.HKD","ASND","LU0320765992.SGD","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2566077176","title":"Ascendis Pharma A/S跌1.78% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2566077176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566077176?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:40","pubTimestamp":1757511619,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时40分，Ascendis Pharma A/S股票出现波动，股价快速跳水1.78%。截至发稿，该股报199.30美元/股，成交量8802股，换手率0.01%，振幅0.64%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.60%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910214019a71bf7e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910214019a71bf7e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","BK4139","ASND","LU0889565916.HKD"],"gpt_icon":0},{"id":"2557578336","title":"Ascendis Pharma A/S盘中异动 股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578336?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:08","pubTimestamp":1754662117,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时08分，Ascendis Pharma A/S股票出现异动，股价大幅跳水5.88%。截至发稿，该股报179.15美元/股，成交量26.6585万股，换手率0.44%，振幅9.75%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.37%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。该公司的产品线包括内分泌学和肿瘤学，其中包括TransCon PTH， TransCon CNP等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220837a47d69f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220837a47d69f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","BK4139","ASND","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2557789331","title":"Ascendis Pharma A/S盘中异动 临近收盘股价大涨5.13%报183.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557789331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557789331?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:50","pubTimestamp":1754337025,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时50分，Ascendis Pharma A/S股票出现波动，股价急速拉升5.13%。截至发稿，该股报183.43美元/股，成交量32.8066万股，换手率0.54%，振幅5.79%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.69%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805035025973392cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805035025973392cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0320765992.SGD","LU0889565916.HKD","BK4139","ASND","LU0109394709.USD"],"gpt_icon":0},{"id":"2550392655","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550392655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550392655?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:56","pubTimestamp":1752069364,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时56分，Ascendis Pharma A/S股票出现波动，股价快速上涨5.12%。截至发稿，该股报176.78美元/股，成交量12.3713万股，换手率0.20%，振幅4.80%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.01%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215604953c3a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215604953c3a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","BK4585","LU0109394709.USD","LU0320765992.SGD","ASND"],"gpt_icon":0},{"id":"2546249409","title":"Ascendis Pharma A/S盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546249409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546249409?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:42","pubTimestamp":1750862550,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时42分，Ascendis Pharma A/S股票出现波动，股价快速下挫5.39%。截至发稿，该股报169.44美元/股，成交量17.2388万股，换手率0.28%，振幅4.94%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.78%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625224230a71d3f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625224230a71d3f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","LU0109394709.USD","LU0889565916.HKD","ASND","LU0320765992.SGD"],"gpt_icon":0},{"id":"2518208844","title":"Ascendis Pharma A/S盘中异动 急速下跌5.16%报138.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208844?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:43","pubTimestamp":1741624985,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时43分，Ascendis Pharma A/S股票出现异动，股价快速下挫5.16%。截至发稿，该股报138.22美元/股，成交量11.4887万股，换手率0.19%，振幅3.85%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.67%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4585","LU0109394709.USD","ASND","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2514097967","title":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097967","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097967?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2512611921","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512611921?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:31","pubTimestamp":1739892667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时31分，Ascendis Pharma A/S股票出现异动，股价急速拉升5.50%。截至发稿，该股报152.00美元/股，成交量16.6641万股，换手率0.28%，振幅4.35%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.59%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","ASND","BK4585","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2511704046","title":"Ascendis Pharma A/S2024财年实现净利润-4.09亿美元，同比增加21.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511704046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511704046?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635295,"startTime":"0","endTime":"0","summary":"2月16日，Ascendis Pharma A/S公布财报，公告显示公司2024财年净利润为-4.09亿美元，同比增加21.35%；其中营业收入为3.93亿美元，同比增加36.46%，每股基本收益为-7.06美元。从资产负债表来看，Ascendis Pharma A/S总负债13.31亿美元，其中短期债务5.09亿美元，资产负债比为0.92，流动比率为1.17。机构评级：截至2025年2月16日，当前有16家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为201.57美元，其中最低目标价为162.69美元，最高目标价为290.23美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2511957350","title":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511957350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511957350?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:38","pubTimestamp":1739468289,"startTime":"0","endTime":"0","summary":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14013848150593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2511525165","title":"Ascendis Pharma A/S盘中异动 大幅拉升12.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525165?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Ascendis Pharma A/S股票出现异动，股价快速上涨12.79%。截至发稿，该股报142.27美元/股，成交量12.7929万股，换手率0.21%，振幅3.97%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.01%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223156abcdb23a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223156abcdb23a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","BK4139","ASND","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"1168353386","title":"异动解读 | Ascendis Pharma A/S股价盘后大涨6.03%,业绩超预期是推手","url":"https://stock-news.laohu8.com/highlight/detail?id=1168353386","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168353386?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:38","pubTimestamp":1739396317,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S在今日盘后交易中股价大涨6.03%,引发市场广泛关注。这家生物科技公司业绩向好的因素推动了股价的上涨。\n\n值得一提的是,Ascendis Pharma在2024年第四季度交出了亮眼的成绩。数据显示,该公司2024年第四季度GAAP每股收益为€-0.64,远好于分析师预期的€-1.07;销售额为€1.73916亿,也高于预期的€1.11178亿。\n\n这一超预期的业绩表现极大增强了投资者对Ascendis Pharma未来发展的信心,市场普遍看好该公司的增长前景。这成为推动公司股价在盘后大涨6.03%的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"gpt_icon":0},{"id":"1116279296","title":"异动解读 | Ascendis Pharma A/S去年第四季度业绩超预期,股价盘中大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116279296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116279296?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:08","pubTimestamp":1739394510,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S今日盘中股价大涨5.87%,引发市场关注。\n\n这家生物科技公司在2024年第四季度实现了亮眼的业绩表现。数据显示,Ascendis Pharma 2024年第四季度GAAP每股收益为€-0.64,远好于分析师预期的€-1.07;销售额为€1.73916亿,也高于预期的€1.11178亿。\n\nAscendis Pharma超预期的业绩给市场带来信心,投资者对公司未来增长前景更加乐观,推动了股价在今日盘中大幅上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"gpt_icon":0},{"id":"1140271421","title":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1140271421","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140271421?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:06","pubTimestamp":1739394386,"startTime":"0","endTime":"0","summary":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿以上内容来自Benzinga Earnings专栏，原文如下：Ascendis Pharma Q4 2024 GAAP EPS €(0.64) Beats €(1.07) Estimate, Sales €173.916M Beat €111.178M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND"],"gpt_icon":0},{"id":"2509916231","title":"Ascendis Pharma A/S盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509916231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509916231?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:18","pubTimestamp":1738775901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时18分，Ascendis Pharma A/S股票出现异动，股价大幅上涨5.01%。截至发稿，该股报128.37美元/股，成交量17.1418万股，换手率0.29%，振幅6.36%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.98%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206011821987b9732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206011821987b9732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","BK4585","LU0889565916.HKD","ASND","LU0109394709.USD"],"gpt_icon":0},{"id":"2507338976","title":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由165.00美元调整至167.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507338976","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507338976?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:12","pubTimestamp":1738156357,"startTime":"0","endTime":"0","summary":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由165.00美元调整至167.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29211247898147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2505501724","title":"Ascendis Pharma A/S盘中异动 早盘股价大跌5.01%报124.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505501724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505501724?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:09","pubTimestamp":1737558553,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时09分，Ascendis Pharma A/S股票出现异动，股价急速下挫5.01%。截至发稿，该股报124.49美元/股，成交量3.9009万股，换手率0.07%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Nutriband Inc.、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为739.75%、140.60%、63.55%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts ，振幅分别为47.48%、41.27%、38.76%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230913a22bba65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230913a22bba65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0320765992.SGD","LU0889565916.HKD","BK4139","ASND","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0634},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.1465},{"period":"1year","weight":0.4456},{"period":"ytd","weight":0.4732}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.028378},{"month":2,"riseRate":0.545455,"avgChangeRate":0.052339},{"month":3,"riseRate":0.454545,"avgChangeRate":0.035071},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.034117},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.003499},{"month":6,"riseRate":0.636364,"avgChangeRate":0.020914},{"month":7,"riseRate":0.636364,"avgChangeRate":0.000335},{"month":8,"riseRate":0.727273,"avgChangeRate":0.084941},{"month":9,"riseRate":0.636364,"avgChangeRate":0.039794},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.00981},{"month":11,"riseRate":0.818182,"avgChangeRate":0.047363},{"month":12,"riseRate":0.454545,"avgChangeRate":0.03752}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}